PuSH - Publication Server of Helmholtz Zentrum München: Effect of empagliflozin on the metabolic signature of patients with type 2 diabetes mellitus and cardiovascular disease.

Navigation

Home

Deutsch

Research

Advanced Search

Browse by ...

... Journal

... Publication Type

... Research Data

... Publication Year

Publication overview

Support & Contact

Contact persons

Help

Data protection

Kappel, B.A.* ; Lehrke, M.* ; Schütt, K.* ; Artati, A. ; Adamski, J. ; Lebherz, C.* ; Marx, N.*

Effect of empagliflozin on the metabolic signature of patients with type 2 diabetes mellitus and cardiovascular disease.

Circulation 136, 969-972 (2017)

Publ. Version/Full Text

DOI

PMC

	Free by publisher

Open Access Green as soon as Postprint is submitted to ZB.

Abstract
Metrics
Extra information

Altmetric

Additional Metrics?

[➜Log in]

Edit extra informations Login

Publication type Article: Journal article

Document type Scientific Article

Corresponding Author

Keywords Sgtl2 Inhibitors ; Branched-chain Amino Acids ; Cardiovascular Disease ; Empagliflozin ; Ketone Bodies ; Metabolomics ; Type 2 Diabetes Mellitus; Hypothesis

ISSN (print) / ISBN 0009-7322

e-ISSN 1524-4539

Journal Circulation

Quellenangaben Volume: 136, Issue: 10, Pages: 969-972

Publisher Lippincott Williams & Wilkins

Publishing Place Philadelphia

Non-patent literature Publications

Reviewing status Peer reviewed

Institute(s) Molekulare Endokrinologie und Metabolismus (MEM)